Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 11, 2004 - Issue 1
Submit an article Journal homepage
272
Views
103
CrossRef citations to date
0
Altmetric
Research Article

Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire

Andrew D. Pitt Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford
,
Andrew F. Smith Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford; Health Economics Unit, Alcon Laboratories (U.K.) Ltd., Hemel Hempstead, Herts., England, U.K
,
Lynda Lindsell Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford
,
Li Wern Voon Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford
,
Peter W. Rose Department of Primary Health Care,Institute of Health Sciences, University of Oxford, Oxford Institute of Health Sciences, Oxford
&
Anthony J. Bron Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford
Pages 17-33 | Published online: 08 Jul 2009

References

  • Leonardi A. Pathophysiology of allergic conjunctivitis. Acta Ophthalmol Scand. 1999;77:21–23.
  • Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99: 22–27.
  • Chapin MJ, George MA, Abelson MB. Olopatadine: Broadening choices for the treatment of allergic conjunctivitis. Todays Therapeutic
  • Dart JKG, Buckley RJ, Monnickendan M, Prasad J. Perennial allergic conjunctivitis: Definition, clinical characteristics and prevalence. Trans Ophthalmol
  • Anderson DF. Management of seasonal allergic conjunctivitis (SAC): current therapeutic strategies Clin Exp Allergy. 2001;31:
  • McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy. 1994;73:35–39.
  • I Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contribution of related airway illnesses. J Allergy Clin Immunol. 1999;103:401–407.
  • Lanier BQ, Gross RD, Marks B, et al. Olopatadine ophthalmic solution nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis. Adv Ther. 2000;17(3):140–147.
  • Alexander M, Allegro S, Hicks A. Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis. Adv Ther. 2000;17(3):140–147.
  • Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21:77–83.
  • Juniper EF. Rhinitis management: the patient's perspective. Clin Exp Allergy. 1998;28(Suppl 6): 34–38.
  • Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104:364–369.
  • Oxfordshire County Council: http://www.oxfordshire.gov.u1c/index/ living/about_our_county/ population_statistics/census_zooz _res ults.htm, 2nd December 2002.
  • EuroQoL EQ-5D: http://www.euroQoL.org/, 2nd December 2002.
  • National Eye Institute VFQ: http://www.nei.nih.gov/resources/ visionfunction/vfq_sa.pdf, 2nd December 2002.
  • Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119: 1050–1058.
  • Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116: 1496–1504.
  • Netten A, Curtis L. Personnel Social Services Research Unit (PSSRU)Unit Costs of Health and Social Care 2002, http://www.ukc.ac.u1c/PSSRU/, 9th September 2002.
  • The Gallup Organisation, Inc. Survey of attitudes and experiences of allergy persons with SAC. December 1989.
  • Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol. 1997;99:5773–780.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.